Nuvectis Pharma Inc (NVCT)

Deferred Revenue

$1.39M

Quarterly · Period ending: · USD

NVCT logo

NVCT Deferred Revenue

Latest reported$1.39M
NVCT Quarterly Deferred Revenue ($0.00 → $1.39M)
High-resolution chart · PNG

NVCT deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuvectis Pharma Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
1,388,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.